Compass Therapeutics, Inc. (NASDAQ:CMPX) announced statistically significant topline data on Tuesday on the primary efficacy ...

Compass Therapeutics has announced top-line data from its ongoing COMPANION-002 trial investigating its antibody-based ...

Tovecimig, formerly known as CTX-009, is a bispecific antibody that blocks the Delta-like ligand 4 and vascular endothelial growth factor A signaling pathways.

First NK Cell Therapy Approval Expected By 2028 Says Kuick Research In Its New Research Study On Global NK Cell Therapy ...

Learn more about whether Haleon plc or Jazz Pharmaceuticals plc is a better investment based on AAII's A+ Investor grades, ...

Researchers laid out nutritional management strategies for clinicians to offer patients before and after bariatric surgery to ...

Learn more about whether Jazz Pharmaceuticals plc or Novo Nordisk A/S is a better investment based on AAII's A+ Investor ...

Zymeworks Inc., a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, ...

An international research team led by the Chinese University of Hong Kong (CUHK) has achieved a breakthrough in the field of ...

As medical imaging technologies continue to evolve, AI-driven solutions like ARDL play a pivotal role in transforming radiology and enhancing diagnostic confidence.